Sevabertinib approved to treat adults with HER2-positive lung cancer that has spread or cannot be removed by surgery
seen at 10:49, 2 April in News and communications.Sevabertinib approved to treat adults with HER2-positive lung cancer that has spread or cannot be removed by surgery
seen at 10:49, 2 April in News and communications.